Gastric Buttons Market is expected to reach US$ 617.9 million by 2028

Publisher: The Insight Partners

The gastric buttons market size is expected to reach US$ 617.9 million by 2028; registering at a CAGR of 7.5% from 2022 to 2028, according to a new research study conducted by The Insight partners

Products Segment to Hold Major Market Share During 2022–2028

The report highlights the trends and drivers prevailing in the market. Increasing prevalence of cancer, neurological disorders, diabetes, and gastrointestinal diseases and rising geriatric population are among the factors contributing to the growing gastric buttons market size.

Based on offerings, the gastric buttons market is bifurcated into products and accessories. The accessories are subsegmented into button feeding sets, button decompression sets, and others. The offerings segment held a larger market share in 2022 and is anticipated to register a higher CAGR during the forecast period. Based on application, the gastric buttons market is divided into children and adults. The children segment held a larger market share in 2022 and is expected to register a higher CAGR during the forecast period. Based on usage, the gastric buttons market is categorized into enteral nutrition, medication, fluids, and others. The enteral nutrition segment held the largest market share in 2022 and is expected to register the highest CAGR during the forecast period. Based on end user, the gastric buttons market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022 and is expected to register the highest CAGR during the forecast period. Based on geography, the gastric buttons market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, the Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, Thailand, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Gastric Buttons Market, by Offerings (%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00029821 Source: The Insight Partners Analysis

Increasing Prevalence of Cancer, Neurological Disorders, Diabetes, and Gastrointestinal Diseases

Diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes. As there is a significant increase in diabetes cases worldwide, it results in life-changing complications among the population. According to the International Diabetes Federation (IDF), in 2017, 46 million diabetic patients were reported in North America, which is expected to reach 62 million in 2045.

Moreover, the data reported that ~425 million people had diabetes in 2017, which is expected to reach 629 million worldwide by 2045. The disease prevalence is expected to increase by ~35% during the forecast period. According to the Alzheimer's Association, in 2018, 5.7 million people had Alzheimer's disease in the Americas.

Cancer is a leading cause of death worldwide. According to the American Society of Clinical Oncology (ASCO), head and neck cancer accounts for ~4% of all cancers in the US. In 2020, ~562,328 individuals were diagnosed with head and neck cancer. Furthermore, in 2020, ~277,597 individuals worldwide died from the disease. Maintaining proper nutrition during cancer treatment is essential. When cancer patients struggle with nutrition, gastric buttons can help provide vitamins, minerals, calories, protein, and fluids required to help the patient fight infection, heal, and stay healthy during cancer treatment which is further expected to drive the growth of gastric buttons market.

Neurological disorders such as Parkinson's disease, dementia, epilepsy and seizures, autism, cerebral palsy, and Alzheimer's disease affect the brain and nerves of the human body. In the US, the prevalence of neurological disorders is increasing. According to the Centers for Disease Control and Prevention (CDC), Alzheimer's disease is one of the top 10 leading causes of death in the US. In 2020, Alzheimer's disease affected 5.8 million people in the US. Similarly, according to the Parkinson's Foundation Prevalence Project, ~930,000 individuals with Parkinson's Disease were present in the US in 2020. Weight loss and malnutrition as suboptimal oral intake are common in patients with neurological disorders and are associated with increased disability, morbidity, and mortality.

Epilepsy is a noncommunicable chronic brain disease that affects people of all ages. According to the World Health Organization (WHO), around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases in the world. Almost 80% of people with epilepsy live in low- and middle-income countries. The same source estimates that up to 70% of people with epilepsy could live seizure-free with proper diagnosis and treatment. The nutritional management of patients with neurological disease is crucial, and enteral feeding is a commonly used method to provide nutritional support. 

A gastrointestinal disease affects the gastrointestinal (GI) tract, the passage that runs from the mouth to the anus. Common GI disorders include irritable bowel syndrome (IBS), acid reflux, indigestion, colon cancer, and hemorrhoids. According to the data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients, ~40% of people have mild IBS, ~35% have moderate IBS, and ~25% have severe IBS. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic colon movements, the abnormal composition of serotonin in the colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. Pancreatic diseases, liver diseases, and inflammatory bowel diseases (IBDs) are often associated with nutritional difficulties and require adequate nutrition to support medical treatment.

The gastrostomy button has recently been used as the enteral route of choice by many doctors and has the cosmetic advantage of being hidden under clothing. Once placed, it can be used for several days.

As chronic diseases are increasing faster, the adoption of the gastrostomy button for the administration of food and medicine has been progressing rapidly over the last five years, which is driving the gastric buttons market.

Impact of COVID-19 Pandemic on Gastric Buttons Market

Countries worldwide witnessed a huge challenge due to the COVID-19 pandemic. Considering the economic operations and geographic conditions, the outbreak affected medical tourism, medical device manufacturers, and other problems posed by the shortage of healthcare infrastructure in low-income countries. The COVID-19 pandemic created a seismic shift in the living standards of the global population. China is specifically facing issues with the pandemic, leading to disruption of the supply chain, projected losses in revenue, product marketing, and sales within all industries, as well as health concerns within the production units and other public places. Moreover, the rising prevalence of various conditions such as cancer, stroke, neurological disorders, and paralysis has further increased the demand for gastric buttons and driving the growth of gastric buttons market.

Several players in the gastric buttons market, including Avanos Medical Inc, Medicina Ltd, danumed Medizintechnik GmbH, Boston Scientific Corp, QMD, Nutricia Ltd, Shin-Etsu Polymer Europe BV, Applied Medical Technology Inc, Fresenius Kabi AG, and Vygon (UK) Ltd., are engaged in addressing the growing demands for gastric buttons.

Contact Us
Contact Person: Content Team 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com